Gene expression profiling suggests PCNSL to be derived from a late germinal center B cell.

From ArrayWiki

(Redirected from GSE6047)
Jump to: navigation, search
PubMed ID: none
Contact: Manuel Montesinos-Rongen

Image:email_GSE6047.png
Columbia University

Species: Homo sapiens
Platform: Affymetrix GeneChip Human Genome U95 Version [1 or 2] Set HG-U95A
Number of Samples: 21
Date Range: 02/25/2003 - 10/07/2005
Experiment Quality: 87.46
2.47 %
92.5
Link to Repository: GSE6047
Original Intensity Data: Download
Clean Intensity Data: Download
Original PLIER Data: Download
Clean PLIER Data: Download
Clean CEL Files: Download
Data Rank:

To characterize the molecular origin of primary lymphomas of the central nervous system (PCNSL), 21 PCNSL of immunocompetent patients were investigated by microarray-based gene expression profiling. Comparison of the transcriptional profile of PCNSL with various normal and neoplastic B cell subsets demonstrated PCNSL (i) to display gene expression patterns most closely related to late germinal center B cells, (ii) to display a gene expression profile similar to systemic diffuse large B cell lymphomas (DLBCL), and (iii) to be in part assigned to the activated B cell-like (ABC) or the germinal center B cell-like (GCB) subtype of DLBCL.

Design: Total RNA was extracted from tissue blocks containing > 80% tumor cells using the TRIzol reagent (Invitrogen, Carlsbad, CA) and purified using RNeasy Kit (Qiagen, Valencia, CA). Double-stranded cDNA (ds-cDNA) was generated from 5 μg of total RNA using the SuperScript Double Stranded cDNA Synthesis Kit (Invitrogen) and a poly-dT oligonucleotide that contains T7 RNA polymerase initiation site (Sigma-Proligo, St. Louis, MO). The ds-cDNA was used as template to generate biotinylated cRNA by in vitro transcription using MEGA-script T7 High Yield Transcription Kit (Ambion, Austin, TX), biotin-11-CTP, and biotin-11-UTP (Perkin Elmer, Altham, MA). The biotinylated cRNA was purified by RNAeasy Kit (Qiagen) and fragmented according to the Affymetrix protocol. 15 μg of fragmented cRNA was hybridized to HG-U95Av2 microarrays (Affymetrix, Santa Clara, CA). Gene expression values were determined by GCOS1.2 software (Affymetrix) using the global scaling option.

Type: PCNSL – DLBCL – gene expression profiling


Contents

[edit] Contributors

  • Manuel Montesinos-Rongen
  • Anna Brunn
  • Stefan Bentink
  • Katia Basso
  • Wei K Lim
  • Wolfram Klapper
  • Carlo Schaller
  • Guido Reifenberger
  • James Rubenstein
  • Otmar D Wiestler
  • Rainer Spang
  • Riccardo Dalla-Favera
  • Reiner Siebert
  • Martina Deckert

[edit] Protocols

[edit] References

[edit] Links

GEO Accession for this experiment: GSE6047. (Public on Dec 16 2007)

RAW data: tar file.

[edit] Analysis

[edit] Samples/Quality Control

Sample Date Scanned Source Link Probe Variance Data Artifact Mask Quality Score
PCNSL biopsy (PCNSL03) 02/25/03 10:57:07 GSM140260 Probe variance for  PCNSL biopsy (PCNSL03) Artifact mask for  PCNSL biopsy (PCNSL03) 87.6063
5.92 %
90.84
PCNSL biopsy (PCNSL04) 02/25/03 11:08:06 GSM140261 Probe variance for  PCNSL biopsy (PCNSL04) Artifact mask for  PCNSL biopsy (PCNSL04) 93.067
1.32 %
95.87
PCNSL biopsy (PCNSL05) 02/25/03 11:19:11 GSM140262 Probe variance for  PCNSL biopsy (PCNSL05) Artifact mask for  PCNSL biopsy (PCNSL05) 92.9266
0.54 %
96.19
PCNSL biopsy (PCNSL06) 02/25/03 11:32:23 GSM140263 Probe variance for  PCNSL biopsy (PCNSL06) Artifact mask for  PCNSL biopsy (PCNSL06) 92.3736
0.63 %
95.87
PCNSL biopsy (PCNSL07) 02/27/03 11:25:05 GSM140264 Probe variance for  PCNSL biopsy (PCNSL07) Artifact mask for  PCNSL biopsy (PCNSL07) 92.5354
0.48 %
96.03
PCNSL biopsy (PCNSL09) 03/04/03 11:27:52 GSM140265 Probe variance for  PCNSL biopsy (PCNSL09) Artifact mask for  PCNSL biopsy (PCNSL09) 93.9954
0 %
97
PCNSL biopsy (PCNSL10) 02/27/03 11:14:14 GSM140266 Probe variance for  PCNSL biopsy (PCNSL10) Artifact mask for  PCNSL biopsy (PCNSL10) 93.7506
0.05 %
96.85
PCNSL biopsy (PCNSL11) 03/04/03 11:39:32 GSM140267 Probe variance for  PCNSL biopsy (PCNSL11) Artifact mask for  PCNSL biopsy (PCNSL11) 93.8948
0.06 %
96.92
PCNSL biopsy (PCNSL14) 03/04/03 11:51:36 GSM140268 Probe variance for  PCNSL biopsy (PCNSL14) Artifact mask for  PCNSL biopsy (PCNSL14) 93.645
0.05 %
96.8
PCNSL biopsy (PCNSL16) 03/04/03 12:21:13 GSM140269 Probe variance for  PCNSL biopsy (PCNSL16) Artifact mask for  PCNSL biopsy (PCNSL16) 91.3143
0.26 %
95.53
PCNSL biopsy (PCNSL17) 03/04/03 13:04:29 GSM140270 Probe variance for  PCNSL biopsy (PCNSL17) Artifact mask for  PCNSL biopsy (PCNSL17) 90.1245
0.63 %
94.75
PCNSL biopsy (PCNSL18) 03/04/03 13:19:41 GSM140281 Probe variance for  PCNSL biopsy (PCNSL18) Artifact mask for  PCNSL biopsy (PCNSL18) 91.4483
0.11 %
95.67
PCNSL biopsy (PCNSL20) 03/04/03 14:38:47 GSM140282 Probe variance for  PCNSL biopsy (PCNSL20) Artifact mask for  PCNSL biopsy (PCNSL20) 93.9402
0.21 %
96.86
PCNSL biopsy (PCNSL21) 03/06/03 11:08:24 GSM140283 Probe variance for  PCNSL biopsy (PCNSL21) Artifact mask for  PCNSL biopsy (PCNSL21) 92.0862
0.62 %
95.73
PCNSL biopsy (PCNSL22) 03/04/03 15:00:06 GSM140284 Probe variance for  PCNSL biopsy (PCNSL22) Artifact mask for  PCNSL biopsy (PCNSL22) 92.8135
0.14 %
96.34
PCNSL biopsy (PCNSL23) 10/04/05 10:33:30 GSM140285 Probe variance for  PCNSL biopsy (PCNSL23) Artifact mask for  PCNSL biopsy (PCNSL23) 91.9954
2.31 %
94.84
PCNSL biopsy (PCNSL24) 10/04/05 11:44:27 GSM140286 Probe variance for  PCNSL biopsy (PCNSL24) Artifact mask for  PCNSL biopsy (PCNSL24) 83.8032
26.71 %
78.55
PCNSL biopsy (PCNSL25) 10/06/05 13:30:41 GSM140287 Probe variance for  PCNSL biopsy (PCNSL25) Artifact mask for  PCNSL biopsy (PCNSL25) 91.0308
2.6 %
94.22
PCNSL biopsy (PCNSL26) 10/04/05 12:24:12 GSM140288 Probe variance for  PCNSL biopsy (PCNSL26) Artifact mask for  PCNSL biopsy (PCNSL26) 91.4249
0.71 %
95.36
PCNSL biopsy (PCNSL27) 10/04/05 13:01:26 GSM140289 Probe variance for  PCNSL biopsy (PCNSL27) Artifact mask for  PCNSL biopsy (PCNSL27) 92.2646
1.08 %
95.59
PCNSL biopsy (PCNSL28) 10/07/05 10:26:47 GSM140290 Probe variance for  PCNSL biopsy (PCNSL28) Artifact mask for  PCNSL biopsy (PCNSL28) 87.9912
9.82 %
89.09